SB379
Psilocybin; Board of Pharmacy to promulgate emergency regulations.
Status:
In Senate
Latest Action:
Feb. 9, 2026
Senate: Engrossed by Senate - committee substitute
Chief Patron:
Jennifer Boysko (D)
Session:
2026 Regular Session
Summary
As Introduced. Board of Pharmacy; regulation of psilocybin.
Directs the Board of Pharmacy to promulgate emergency regulations that allow for prescribing, dispensing, possessing, and using of FDA-approved formulations of psilocybin designed to be administered by a health care professional in a health care setting following rescheduling by the U.S. Drug Enforcement Administration.-
Bill History
- 01/13/2026 - Senate: Prefiled and ordered printed; Offered 01-14-2026 26104820D
- 01/13/2026 - Senate: Referred to Committee on Education and Health
- 01/29/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB379)
- 01/30/2026 - Senate: Assigned Education sub: Health Professions
- 01/30/2026 - Senate: Senate subcommittee offered
- 02/05/2026 - Senate: Reported from Education and Health with substitute (14-Y 0-N)
- 02/06/2026 - Senate: Committee substitute printed 26106612D-S1
- 02/06/2026 - Senate: Rules suspended
- 02/06/2026 - Senate: Constitutional reading dispensed (on 1st reading) (39-Y 0-N 0-A)
- 02/06/2026 - Senate: Passed by for the day (Voice Vote)
- 02/09/2026 - Senate: Read second time
- 02/09/2026 - Senate: Committee substitute agreed to (Voice Vote)
- 02/09/2026 - Senate: Engrossed by Senate (Voice Vote)
- 02/09/2026 - Senate: Engrossed by Senate - committee substitute
